A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

By Sharma Anita   Walters James   Gozes Yehoshua   Fridkin Mati   Brennman Douglas   Gozes Illana   Moody Terry  

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 331-339

Humana Press, Inc

Access to resources Recommend Favorite

Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

By Karacay Bahri   O’Dorisio M.Sue   Kasow Kim   Hollenback Clay   Krahe Ralf  

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 311-324

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome

By Hill J.M.   Ades A.M.   McCune S.K.   Sahir N.   Moody E.M.   Abebe D.T.   Crnic L.S.   Brenneman D.E.  

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 56-65

Elsevier

Access to resources Recommend Favorite

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro

By Dufes Christine   Alleaume Céline   Montoni Alicia   Olivier Jean-Christophe   Muller Jean-Marc  

Journal of Molecular Neuroscience, Vol. 21, Iss. 2, 2003-06 ,pp. : 91-102

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

By  

Journal of Molecular Neuroscience, Vol. 33, Iss. 3, 2007-11 ,pp. : 278-283

Humana Press, Inc

Access to resources Recommend Favorite